Prepartum 2,4-thiazolidinedione alters metabolic dynamics and dry matter intake of dairy cows.
Thiazolidinediones (TZD) are potent, synthetic ligands for peroxisome proliferator activated receptor-gamma (PPAR-gamma) that reduce plasma nonesterified fatty acids (NEFA) and potentiate the action of insulin in peripheral tissues of several species. Holstein cows (n = 9) entering their second or greater lactation were used to determine whether late prepartum administration of TZD would affect periparturient metabolism and milk production. Cows were limit-fed a total mixed ration (TMR) during the prepartum period to provide no more than 130% of predicted energy requirements. During the postpartum period cows were fed a common TMR for ad libitum intake. Cows were administered either 2,4-TZD (4.0 mg/kg of body weight) or saline (control) by intrajugular infusion once daily from 25 d before expected parturition until parturition. Plasma samples were collected daily from 26 d before expected parturition through 7 d postpartum. Plasma NEFA concentrations decreased during the prepartum period (d -21 to -1; 70 vs. 83 +/- 4 microEq/L) and tended to be decreased during the peripartum period (d -7 to d +7; 113 vs. 205 +/- 32 microEq/L) due to prepartum TZD administration. Plasma concentrations of glucose were not affected by treatment; however, plasma beta-hydroxybutyrate concentrations decreased in TZD-treated cows (8.6 vs. 10.7 +/- 1.7 mg/dL) as parturition approached, and plasma insulin concentrations increased during the peripartum period (0.65 vs. 0.38 +/- 0.07 ng/mL). Postpartum liver triglyceride and glycogen content was not affected by treatment. Prepartum TZD administration tended to increase dry matter intake during the peripartum and postpartum periods (16.6 vs. 14.6 +/- 0.8 kg/d and 20.0 vs. 17.2 +/- 1.2 kg/d, respectively). Milk yield for the first 30 d postpartum and milk composition measured on d 8 postpartum were not affected by treatment. There was no effect of prepartum TZD administration on insulin-dependent glucose utilization assessed using insulin challenge during either the prepartum or postpartum periods. These results suggest that administration of TZD during the late prepartum period has the potential to improve metabolic health and DMI of periparturient dairy cows and warrants further investigation.
Smith
K L
KL
Department of Animal Science, Cornell University, Ithaca, NY 14853, USA.
Stebulis
S E
SE
Waldron
M R
MR
Overton
T R
TR
D020155:3-Hydroxybutyric Acid / Q000097:blood; D000821:Animal Feed / Q000032:analysis; D000818:Animals; D001774:Blood Chemical Analysis / Q000662:veterinary; D001786:Blood Glucose / Q000032:analysis / Q000187:drug effects; D002417:Cattle / Q000378:metabolism*; D003612:Dairying; D004435:Eating / Q000187:drug effects*; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D007774:Lactation / Q000187:drug effects; D008099:Liver / Q000737:chemistry / Q000187:drug effects; D011247:Pregnancy; D012965:Sodium Chloride / Q000008:administration & dosage / Q000494:pharmacology; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D012965:Sodium Chloride; C089946:2,4-thiazolidinedione; D020155:3-Hydroxybutyric Acid